TIL Counting and Immune Cell Killing: Dual-Cassette Optimization Guide

The Bottom Line Up Front: TIL counting and immune cell killing assays are immediate applications for dual-cassette workflows. Cancer cells are large, T cells are small - no single cassette optimizes both. Run S+ or S for accurate T cell counts, M+ or M for accurate tumor/target counts. The extra run takes minutes but delivers publication-quality E:T ratios and killing percentages.
WHICH CASSETTES FOR YOUR INSTRUMENT

Moxi V and Moxi GO II use S+ and M+ cassettes. Moxi Z uses S and M cassettes. Same sizing principles, same selection logic — just match the cassette type to your instrument. All recommendations in this guide apply across the Moxi family.

Why Immuno-Oncology Demands Dual-Cassette Workflows

Immuno-oncology applications inherently combine cells from opposite ends of the size spectrum. This isn't a corner case - it's the fundamental nature of the field. T cells are 6-10 micrometers, NK cells are 10-12 micrometers, and tumor cells are 15-30+ micrometers.

Single-cassette measurement forces compromise: either undercount small lymphocytes (M+ cassette with weak signals) or risk clogging on tumor cells (S+ cassette with oversized cells). Neither gives you accurate data for both populations.

TL;DR - Immuno-Oncology Workflow Essentials

  • TIL counting: T cells (6-10 μm) + tumor cells (15-30 μm) = mandatory dual-cassette application
  • Immune killing assays: small effectors + large targets = same dual-cassette requirement
  • S+ or S for lymphocytes/effectors, M+ or M for tumor/target cells
  • Calculate E:T ratios from optimized individual measurements, not compromised single-cassette data
  • Single-cassette shortcuts introduce systematic error into every ratio calculation

Immuno-Oncology Dual-Cassette Protocols

Complete workflows for TIL counting, cytotoxicity assays, and accurate ratio calculations.

Why Immuno-Oncology Demands Dual-Cassette Workflows

Immuno-oncology applications inherently combine cells from opposite ends of the size spectrum. This isn't a corner case - it's the fundamental nature of the field:

T cells: 6-10 micrometers - firmly in S+ cassette territory

NK cells: 10-12 micrometers - still within S+ optimal range

Tumor cells: 15-30+ micrometers - requires M+ cassettes

TIL counting represents one of the immediate applications for dual-cassette workflows. The same is true for all immune cell killing assays: cancer cell big, your T cell small.

Single-cassette measurement forces compromise: either undercount small lymphocytes (M+ cassette with weak signals) or risk clogging on tumor cells (S+ cassette with oversized cells). Neither gives you accurate data for both populations.

TIL Counting: Complete Workflow

Tumor-infiltrating lymphocyte quantification requires accurate counts of both infiltrating T cells and tumor cells to calculate meaningful infiltration ratios:

1 Prepare single-cell suspension from tumor sample (enzymatic or mechanical dissociation)
2 Run first aliquot with S+ or S cassette - record T cell count and size distribution
3 Run second aliquot with M+ or M cassette - record tumor cell count and size distribution
4 Calculate infiltration ratio: TIL count (S+) / tumor count (M+)
5 Report optimized values for each population with cassette method documented

The extra cassette change and measurement takes a few minutes. The alternative - systematic error in one or both populations - corrupts all downstream analysis.

Immune Cell Killing Assays: Protocol Optimization

Cytotoxicity assays quantify immune cell killing through effector:target ratios and surviving target counts. Accurate counts of both populations are essential:

CAR-T Cytotoxicity

CAR-T cells (8-12 μm) vs tumor target cells (15-25 μm). Set up E:T ratios using S+ counts for effectors, M+ counts for targets. Track killing by M+ target cell counts over time.

NK Cell Killing

NK cells (10-12 μm) vs cancer cell lines (15-30 μm). Dual-cassette workflow captures both populations optimally for accurate killing percentage calculations.

ADCC Assays

Effector cells (PBMCs, 8-15 μm) plus antibody vs target cells (tumor lines, 15-25 μm). S+ for effector quantification, M+ for target survival assessment.

All immune cell killing assays share this structure: small effector, large target. Dual-cassette workflows aren't optional for publication-quality data.

Calculating Ratios from Dual-Cassette Data

Proper calculation uses the optimized count from each cassette measurement:

E:T Ratio Calculation:

E:T Ratio = Effector count (S+ cassette) / Target count (M+ cassette)

Killing Percentage:

% Killing = [1 - (Targets at Tx / Targets at T0)] × 100

Both target counts from M+ cassette measurements at different timepoints.

Why This Matters

Single-cassette measurements introduce bias in one population. If you undercount effectors (M+ cassette for small cells), your E:T ratio is artificially low. If you undercount targets (S+ clogging on large cells), your killing percentage is artificially high. Both errors propagate through all calculations.

Documentation and Method Reporting

For publications and regulatory submissions, document your dual-cassette methodology clearly:

Methods section language: "Cell counts were obtained using Moxi [model] with cassette selection optimized for cell size. Lymphocyte/effector populations were quantified using S+ cassettes (optimal for cells <15 μm). Tumor/target cells were quantified using M+ cassettes (optimal for cells >15 μm). E:T ratios were calculated using optimized counts from each population."

Supporting rationale: Reference the Coulter principle physics and cell-to-aperture optimization. This isn't an unusual method - it's the technically correct approach for heterogeneous populations.

Data presentation: Include cassette type in your data tables. Reviewers should see that you measured each population appropriately, not that you forced compromise on one or both.

Troubleshooting Guide

T cell counts seem low in tumor digests
Solution: Verify you're using S+ or S cassettes for T cell quantification. Small lymphocytes generate weak signals in M+ or M cassettes, causing undercounting.
Clogging when counting tumor samples
Solution: Use M+ or M cassettes for tumor cell counts. Large tumor cells clog S+ or S apertures. If clogging persists, verify dissociation quality - clumps clog even appropriate apertures.
E:T ratios don't match expected setup
Solution: Check that you're using S+ for effector counts and M+ for target counts. Using the same cassette for both introduces systematic bias that skews ratios.
Killing percentages seem artificially high
Solution: If target cells are clogging S+ cassettes, you're undercounting survivors. Switch to M+ for target counts to get accurate surviving cell numbers.

Frequently Asked Questions

How do I accurately count TILs in tumor samples?
TIL counting requires dual-cassette workflows because T cells (6-10 micrometers) and tumor cells (15-30+ micrometers) span both sides of the 15-micrometer boundary. Run with S+ cassettes for accurate T cell quantification, then M+ cassettes for tumor cell counts. This gives you optimized counts for both populations to calculate accurate infiltration ratios.
What cassettes should I use for immune cell killing assays?
Immune cell killing assays pair small effector cells (T cells, NK cells at 6-12 micrometers) with large target cells (cancer cells at 15-30 micrometers). Use S+ cassettes for effector cell counts and M+ cassettes for target cell counts. This dual-cassette approach provides accurate E:T ratios and killing percentage calculations.
How do I calculate E:T ratios from dual-cassette measurements?
Use the optimized count from each cassette: effector counts from S+ measurements, target counts from M+ measurements. Calculate E:T ratio = (effector count from S+) / (target count from M+). This gives more accurate ratios than any single-cassette compromise measurement could provide.
Can I use a single cassette for immune cell killing assays?
Technically yes, but with significant accuracy trade-offs. M+ cassettes will undercount small effector cells, inflating apparent E:T ratios. S+ cassettes risk clogging with large target cells and may undercount them. Dual-cassette workflows take extra minutes but provide accurate counts for publication-quality data.

Key Takeaway

Immuno-oncology applications are built on size mismatches between effector and target cells. TIL counting, CAR-T cytotoxicity, NK killing, ADCC - all require accurate counts of both small and large cells. Dual-cassette workflows using S+ or S for lymphocytes and M+ or M for tumor cells deliver the accurate ratios your research depends on. The alternative isn't "good enough" data - it's systematically biased data that propagates error through every calculation.

Back to all resources

Similar resources